期刊文献+

TNNI3K抑制剂3D-QSAR的研究及虚拟筛选 被引量:1

Virtual Screening and 3D-QSAR Study of TNNI3K Inhibitors
在线阅读 下载PDF
导出
摘要 通过一系列肌钙蛋白Ⅰ相关激酶抑制剂苯磺酰胺衍生物构建了其3D-QSAR模型,研究其结构与活性关系。所得CoMFA、TopomerCoMFA模型的交叉验证相关系数q2分别为0.622、0.768,非交叉验证系数r2分别为0.952、0.981,外部验证相关系数R2pred分别为0.823、0.754,说明模型具有良好的预测性能和稳定性。采用Topomer Search对ZINC数据库进行虚拟筛选,共得到25个分子,其预测活性均高于活性最高的模板分子。最后通过分子对接筛选得到11个分子可作为TNNI3K抑制剂进一步研究。 Three dimensional structure-activity relationships(3 D-QSAR)models were constructed with a series of Troponin I-interacting protein Kinase inhibitors benzyl sulfonamide derivatives to investigate the structure-activity relationship. The cross-validate regress coefficients(q2)of CoMFA and TopomerCoMFA were0.622,0.768,and the noncross-validate regress coefficients(r2)were 0.952,0.981,respectively. However,theexternal validation coefficients(r2 pred) of CoMFA and TopomerCoMFA were 0.823, 0.754 respectively,indicating that both models are favorable stable and predictable. Moreover,Topomer Search was utilized forvirtual screening in ZINC database,and 25 new molecules were obtained,which exhibited higher activitycompared with those template molecules. Finally,11 molecules were screened by molecular docking as the potential inhibitors of TNNI3 K.
作者 徐闻曦 蔡晓然 郑小娇 刘根炎 巨修练 XU Wenxi;CAI Xiaoran;ZHENG Xiaojiao;LIU Genyan;JU Xiulian(School of Chemical Engineering and Pharmacy,Wuhan Institute of Technology,Wuhan 430205,China)
出处 《武汉工程大学学报》 CAS 2018年第5期485-493,共9页 Journal of Wuhan Institute of Technology
关键词 肌钙蛋白Ⅰ相关激酶抑制剂 COMFA 分子对接 虚拟筛选 troponin I-interacting protein kinase inhibitors CoMFA docking virtual screening
  • 相关文献

参考文献1

二级参考文献36

  • 1王林,王慧,叶珏,宋莉,孟宪敏.腺病毒过表达TNNI3K基因对成年大鼠心肌细胞肌丝钙敏感度的影响[J].中国分子心脏病学杂志,2011,11(2):83-87. 被引量:2
  • 2冯艳,刘冬青,王震,曹慧青,时娜,邓仲端,丁金凤,孟宪敏.心肌特异性新蛋白激酶p93和peroxiredoxin3的相互作用[J].生物化学与生物物理进展,2004,31(8):688-692. 被引量:3
  • 3尤昕,时娜,柳明洙,曹慧青,刘冬青,孟宪敏.心肌特异表达基因p93的激酶及丝氨酸结构域在大肠杆菌中的高效表达[J].中国分子心脏病学杂志,2004,4(6):330-333. 被引量:2
  • 4郑晓静,刘冬青,时娜,曹慧青,田野,王来元,孟宪敏.心肌特异表达基因p93在四种心血管疾病中血清水平的差异及其意义[J].中华检验医学杂志,2006,29(8):704-707. 被引量:3
  • 5Zhao Y, Meng X. M, Wei Y. J, et al. Cloning and characterization of a novel cardiac-specific kinase that interacts specifically with cardiac troponin I. J Mol Med (Berl), 2003, 81(5):297-304.
  • 6Wang H, Wang L, Song L, et al. TNNI3K is a novel mediator of myofilament function and phosphorylates cardiac troponin I. Braz J Med Biol Res, 2013, 46(2): 128-137.
  • 7Lai Z. F, Chen Y. Z, Feng L. P, et al. Overexpression of TNNI3K, a cardiac-specific MAP kinase, promotes P19CL6- derived cardiac myogenesis and prevents myocardial infarction- induced injury. Am J Physiol Heart Circ Physiol, 2008, 295(2): H708-H716.
  • 8Wang H, Chen C, Song X, et al. Mef2c is an essential regulatory element required for unique expression of the cardiac-specific CARK gene. J Cell Mol Med, 2008, 12(1): 304- 315.
  • 9Vagnozzi R. J, Gatto G. J, Kallander L. S, et al. Inhibition of the cardiomyoeyte-speeific kinase TNNI3K limits oxidative stress, injury, and adverse remodeling in the isehemic heart. Sci Transl Med, 2013, 5(207): 141r-207r.
  • 10Zhu Y, Lu L, Xu L, et al. Identification of a gp41 core- binding molecule with homologous sequence of human TNNI3K-like protein as a novel human immunodeficiency virus type 1 entry inhibitor. J Virol, 2010, 84(18): 9359-9368.

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部